Your browser doesn't support javascript.
loading
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.
Palandri, Francesca; Palumbo, Giuseppe A; Abruzzese, Elisabetta; Iurlo, Alessandra; Polverelli, Nicola; Elli, Elena; Bonifacio, Massimiliano; Bergamaschi, Micaela; Martino, Bruno; Tiribelli, Mario; Benevolo, Giulia; Tieghi, Alessia; Sgherza, Nicola; Isidori, Alessandro; Binotto, Gianni; Crugnola, Monica; Heidel, Florian; Cavazzini, Francesco; Bosi, Costanza; Auteri, Giuseppe; Cattaneo, Daniele; Foà, Robin; Lemoli, Roberto M; Cuneo, Antonio; Krampera, Mauro; Bartoletti, Daniela; Cavo, Michele; Vianelli, Nicola; Breccia, Massimo; Latagliata, Roberto.
  • Palandri F; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Palumbo GA; Division of Hematology, AOU "Policlinico-V. Emanuele", University of Catania, Catania, Italy.
  • Abruzzese E; Division of Hematology, Ospedale S. Eugenio, Rome, Italy.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Polverelli N; Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Elli E; Hematology Division, San Gerardo Hospital, ASST Monza, Monza, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Bergamaschi M; Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Clinic of Hematology, Genoa, Italy.
  • Martino B; Division of Hematology, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria, Italy.
  • Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Benevolo G; Division of Hematology, Città della Salute e della Scienza Hospital, Torino, Italy.
  • Tieghi A; Department of Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Sgherza N; Division of Hematology, Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy.
  • Isidori A; Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy.
  • Binotto G; Unit of Hematology and Clinical Immunology, University of Padova, Padova, Italy.
  • Crugnola M; Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Heidel F; Internal Medicine II, Hematology and Oncology, Friedrich-Schiller-University Medical Center, Jena, Germany.
  • Cavazzini F; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Bosi C; Division of Hematology, AUSL di Piacenza, Piacenza, Italy.
  • Auteri G; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Foà R; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
  • Lemoli RM; Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Clinic of Hematology, Genoa, Italy.
  • Cuneo A; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Krampera M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Bartoletti D; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Cavo M; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Vianelli N; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Breccia M; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
  • Latagliata R; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy.
Hematol Oncol ; 37(4): 418-423, 2019 Oct.
Article en En | MEDLINE | ID: mdl-30985017
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Inhibidores de Proteínas Quinasas / Mielofibrosis Primaria / Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Inhibidores de Proteínas Quinasas / Mielofibrosis Primaria / Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article